$AGN Allergan plc Insider Trading Week 23/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allergan plc in week 23/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | M | 82.53 | 2,200 | 181,566 | 2,759 | |
Jun 10 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | S | 297.89 | 2,200 | 655,358 | 4,286 | 6.5 K to 4.3 K (-33.92 %) |
Jun 10 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | M | 82.53 | 2,200 | 181,566 | 6,486 | 4.3 K to 6.5 K (+51.33 %) |
Jun 08 2015 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 302.30 | 826 | 249,700 | 2,826 | 2 K to 2.8 K (+41.30 %) |
Jun 08 2015 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 303.38 | 334 | 101,329 | 2,000 | 2.3 K to 2 K (-14.31 %) |
Jun 08 2015 | AGN | Allergan plc | WEISS FRED G | Director | Grant | A | 302.30 | 826 | 249,700 | 25,694 | 24.9 K to 25.7 K (+3.32 %) |
Jun 08 2015 | AGN | Allergan plc | WEISS FRED G | Director | Payment of Exercise | F | 303.38 | 549 | 166,556 | 24,868 | 25.4 K to 24.9 K (-2.16 %) |
Jun 08 2015 | AGN | Allergan plc | BLOEM JAMES H | Director | Grant | A | 302.30 | 826 | 249,700 | 9,219 | 8.4 K to 9.2 K (+9.84 %) |
Jun 08 2015 | AGN | Allergan plc | BLOEM JAMES H | Director | Payment of Exercise | F | 303.38 | 549 | 166,556 | 8,393 | 8.9 K to 8.4 K (-6.14 %) |
Jun 08 2015 | AGN | Allergan plc | BODINE CHRIS W | Director | Grant | A | 302.30 | 826 | 249,700 | 13,048 | 12.2 K to 13 K (+6.76 %) |
Jun 08 2015 | AGN | Allergan plc | BODINE CHRIS W | Director | Payment of Exercise | F | 303.38 | 549 | 166,556 | 12,222 | 12.8 K to 12.2 K (-4.30 %) |
Jun 08 2015 | AGN | Allergan plc | TAYLOR RONALD R | Director | Grant | A | 302.30 | 826 | 249,700 | 23,361 | 22.5 K to 23.4 K (+3.67 %) |
Jun 08 2015 | AGN | Allergan plc | TAYLOR RONALD R | Director | Payment of Exercise | F | 303.38 | 549 | 166,556 | 22,535 | 23.1 K to 22.5 K (-2.38 %) |
Jun 08 2015 | AGN | Allergan plc | O'Sullivan Patrick J | Director | Grant | A | 302.30 | 826 | 249,700 | 3,689 | 2.9 K to 3.7 K (+28.85 %) |
Jun 08 2015 | AGN | Allergan plc | O'Sullivan Patrick J | Director | Payment of Exercise | F | 303.38 | 549 | 166,556 | 2,863 | 3.4 K to 2.9 K (-16.09 %) |
Jun 08 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 302.30 | 826 | 249,700 | 4,286 | 3.5 K to 4.3 K (+23.87 %) |
Jun 08 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 303.38 | 334 | 101,329 | 3,460 | 3.8 K to 3.5 K (-8.80 %) |
Jun 08 2015 | AGN | Allergan plc | GALLAGHER MICHAEL R | Director | Grant | A | 302.30 | 826 | 249,700 | 1,858 | 1 K to 1.9 K (+80.04 %) |
Jun 08 2015 | AGN | Allergan plc | McDonnell Peter J | Director | Grant | A | 302.30 | 826 | 249,700 | 2,891 | 2.1 K to 2.9 K (+40.00 %) |
Jun 08 2015 | AGN | Allergan plc | KLEMA CATHY | Director | Grant | A | 302.30 | 826 | 249,700 | 21,027 | 20.2 K to 21 K (+4.09 %) |
Jun 08 2015 | AGN | Allergan plc | KLEMA CATHY | Director | Payment of Exercise | F | 303.38 | 549 | 166,556 | 20,201 | 20.8 K to 20.2 K (-2.65 %) |